Nanoform Finland Oyj

As of June 30, 2026, Nanoform Finland Oyj carries a market capitalization of 728.06M, placing it among publicly traded companies globally. Its enterprise value stands at 588.45M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Nanoform Finland Oyj's next confirmed earnings release is scheduled for November 11, 2026.

As of June 30, 2026, Nanoform Finland Oyj has 85.75M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 16.52, and the price-to-book ratio stands at 1.81.

These figures are as of June 30, 2026. The EV/Sales ratio of 13.11 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 588.45M versus a market cap of 728.06M, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Nanoform Finland Oyj maintains a current ratio of 3.12, meaning it holds 3.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 17.71, indicating elevated leverage, while an interest coverage ratio of -37.87 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Nanoform Finland Oyj posted a negative return on equity (ROE) of -32.12, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -24.92, reflecting losses generated across the asset base. The company generates approximately 258,682.00 in revenue per employee across its workforce of 173.50, a quick read on workforce productivity versus industry peers. Inventory turnover of 1.90 indicates how many times Nanoform Finland Oyj sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Nanoform Finland Oyj recorded 332,290.19 in income tax expense. The company reported a pretax loss of -151.88M and -152.21M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 22, 2026, Nanoform Finland Oyj's stock has declined approximately 39.20% over the past 52 weeks. The 50-day moving average sits at 9.77, while the 200-day moving average is 8.73.

Over the twelve months ended June 30, 2026, Nanoform Finland Oyj generated 44.88M in revenue and converted that into -152.21M in net income, yielding earnings per share of -1.74. EBITDA reached -125.01M, while operating income came in at -181.77M.

As of June 30, 2026, Nanoform Finland Oyj holds 210.79M in cash and equivalents against 71.19M in total debt, resulting in a net debt position of -191.59M. Total book value stands at 401.88M, with working capital of 155.32M providing operational flexibility.

Nanoform Finland Oyj produced -149.26M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -12.69M in capital expenditures, free cash flow totaled -161.96M - equivalent to -1.85 per share.

Over the twelve months ended June 30, 2026, Nanoform Finland Oyj posted a gross margin of 86.99, reflecting its pricing power and cost economics. The operating margin of -405.01 and net profit margin of -339.14 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -21.84: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield reaches 0.64, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Nanoform Finland Oyj shareholders.

As of June 30, 2026, Nanoform Finland Oyj has an Altman Z-Score of -1.22, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.